Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
59.47
+0.27 (0.46%)
At close: Apr 9, 2026, 4:00 PM EDT
59.41
-0.06 (-0.10%)
After-hours: Apr 9, 2026, 4:10 PM EDT
BMY Employees
Bristol-Myers Squibb Company had 32,500 employees as of December 31, 2025. The number of employees decreased by 1,600 or -4.69% compared to the previous year.
Employees
32,500
Change (1Y)
-1,600
Growth (1Y)
-4.69%
Revenue / Employee
$1,482,892
Profits / Employee
$217,046
Market Cap
121.42B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 32,500 | -1,600 | -4.69% |
| Dec 31, 2024 | 34,100 | 0 | - |
| Dec 31, 2023 | 34,100 | -200 | -0.58% |
| Dec 31, 2022 | 34,300 | 2,100 | 6.52% |
| Dec 31, 2021 | 32,200 | 1,950 | 6.45% |
| Dec 31, 2020 | 30,250 | 250 | 0.83% |
| Dec 31, 2019 | 30,000 | 6,700 | 28.76% |
| Dec 31, 2018 | 23,300 | -400 | -1.69% |
| Dec 31, 2017 | 23,700 | -1,300 | -5.20% |
| Dec 31, 2016 | 25,000 | 0 | - |
| Dec 31, 2015 | 25,000 | 0 | - |
| Dec 31, 2014 | 25,000 | -3,000 | -10.71% |
| Dec 31, 2013 | 28,000 | 0 | - |
| Dec 31, 2012 | 28,000 | 1,000 | 3.70% |
| Dec 31, 2011 | 27,000 | 0 | - |
| Dec 31, 2010 | 27,000 | -1,000 | -3.57% |
| Dec 31, 2009 | 28,000 | -7,000 | -20.00% |
| Dec 31, 2008 | 35,000 | -7,000 | -16.67% |
| Dec 31, 2007 | 42,000 | -1,000 | -2.33% |
| Dec 31, 2006 | 43,000 | 0 | - |
| Dec 31, 2005 | 43,000 | 0 | - |
| Dec 31, 2004 | 43,000 | -1,000 | -2.27% |
| Dec 31, 2003 | 44,000 | 0 | - |
| Dec 31, 2002 | 44,000 | -2,000 | -4.35% |
| Dec 31, 2001 | 46,000 | 2,000 | 4.55% |
| Dec 31, 2000 | 44,000 | -10,500 | -19.27% |
| Dec 31, 1999 | 54,500 | -200 | -0.37% |
| Dec 31, 1998 | 54,700 | 1,100 | 2.05% |
| Dec 31, 1997 | 53,600 | 2,400 | 4.69% |
| Dec 31, 1996 | 51,200 | 2,060 | 4.19% |
| Dec 31, 1995 | 49,140 | 1,440 | 3.02% |
| Dec 31, 1994 | 47,700 | -1,800 | -3.64% |
| Dec 31, 1993 | 49,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 95,100 |
| Novartis AG | 75,267 |
| Pfizer | 75,000 |
| Merck & Co. | 75,000 |
| Sanofi | 74,846 |
| Novo Nordisk | 69,505 |
| GSK plc | 66,841 |
| AbbVie | 57,000 |
BMY News
- 9 hours ago - Oxford BioTherapeutics Enters Strategic Collaboration with Bristol Myers Squibb to Discover and Develop Next-Generation T-cell Engagers for Solid Tumours - GlobeNewsWire
- 2 days ago - 15 stocks to put on your list to buy when the market recovers - Market Watch
- 6 days ago - Swiss industry body says US tariffs on pharmaceuticals will harm patients - Reuters
- 6 days ago - Trump Administration Unveils Up to 100% Tariff on Branded Drugs - WSJ
- 6 days ago - Trump threatens 100% tariff on US drug makers that don't strike deals to lower prices - The Guardian
- 7 days ago - Drugmakers face 100% tariff unless they cut prices or produce drugs in US - Reuters
- 7 days ago - Global pharma companies that have publicly announced Trump drug pricing agreements - Reuters
- 9 days ago - Bristol Myers Squibb Evolves and Expands Standing in the Gaap to Advance More Equitable Care in Multiple Myeloma as Program Marks Ten Years - Business Wire